The Effects of Cannabidiol on the Driving Performance of Healthy Adults by Dose and Sex
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-30
SponsorWest Virginia University
About this trial
The objectives/purpose of this study are to comprehensively investigate the effects of non-prescription CBD on driving performance, drowsiness, sedation, and cognitive function in a large sample of healthy adults aged 18-30 years, with additional characterization of effects by dose and by sex, using a rigorous RCT design which will naturally mitigate confounding factors.
Eligibility criteria
Qualifiers
Possess a current drivers' license
Driven a motor vehicle at least once in the past 30 days
Able to read English
Test negative for all substances on a urine drug test and complete a test drive to ensure the absence of simulation sickness
Disqualifiers
Currently smoke, vape or use tobacco products, used CBD in the past 30 days
Used illegal drugs in the past 30 days (e.g., cocaine/crack, heroin, methamphetamine, 3,4-methylenedioxy-methamphetamine, inhalants, phencyclidine, lysergic acid diethylamide, psilocybin mushrooms, or marijuana)
Are pregnant or lactating at time of study
Trial design
Treatments tested in this trial
- Cannabidiol (CBD) Oil 300mg
- Cannabidiol (CBD) Oil 150mg
- Placebo Oil
Treatment groups
300 Participants
are divided into 3 treatment groupsSponsors and collaborators
West Virginia University
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
Source ClinicalTrials.gov